Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 148


Progress Toward Measles Elimination - China, January 2013-June 2019.

Ma C, Rodewald L, Hao L, Su Q, Zhang Y, Wen N, Fan C, Yang H, Luo H, Wang H, Goodson JL, Yin Z, Feng Z.

MMWR Morb Mortal Wkly Rep. 2019 Dec 6;68(48):1112-1116. doi: 10.15585/mmwr.mm6848a2.


Review of the status and challenges associated with increasing influenza vaccination coverage among pregnant women in China.

Zhou S, Greene CM, Song Y, Zhang R, Rodewald LE, Feng L, Millman AJ.

Hum Vaccin Immunother. 2019 Oct 7:1-10. doi: 10.1080/21645515.2019.1664230. [Epub ahead of print]


The Global Vaccine Action Plan - insights into its utility, application, and ways to strengthen future plans.

Daugherty MA, Hinman AR, Cochi SL, Garon JR, Rodewald LE, Nowak G, McKinlay MA, Mast EE, Orenstein WA.

Vaccine. 2019 Aug 14;37(35):4928-4936. doi: 10.1016/j.vaccine.2019.07.042. Epub 2019 Jul 17.


Compliance among infants exposed to hepatitis B virus in a post-vaccination serological testing program in four provinces in China.

Zheng H, Zhang GM, Chan PL, Wang FZ, Rodewald LE, Miao N, Sun XJ, Yin ZD, Edwards J, Wang HQ.

Infect Dis Poverty. 2019 Jul 4;8(1):57. doi: 10.1186/s40249-019-0568-y.


Evaluating vaccination policies to accelerate measles elimination in China: a meta-population modelling study.

Hao L, Glasser JW, Su Q, Ma C, Feng Z, Yin Z, Goodson JL, Wen N, Fan C, Yang H, Rodewald LE, Feng Z, Wang H.

Int J Epidemiol. 2019 Aug 1;48(4):1385. doi: 10.1093/ije/dyz103. No abstract available.


Evaluating vaccination policies to accelerate measles elimination in China: a meta-population modelling study.

Hao L, Glasser JW, Su Q, Ma C, Feng Z, Yin Z, Goodson JL, Wen N, Fan C, Yang H, Rodewald LE, Feng Z, Wang H.

Int J Epidemiol. 2019 Aug 1;48(4):1240-1251. doi: 10.1093/ije/dyz058. Erratum in: Int J Epidemiol. 2019 Aug 1;48(4):1385.


Immunogenicity and safety of measles-rubella vaccine co-administered with attenuated Japanese encephalitis SA 14-14-2 vaccine in infants aged 8 months in China: a non-inferiority randomised controlled trial.

Li Y, Chu SY, Yue C, Wannemuehler K, Xie S, Zhang F, Wang Y, Zhang Y, Ma R, Li Y, Zuo Z, Rodewald L, Xiao Q, Feng Z, Wang H, An Z.

Lancet Infect Dis. 2019 Apr;19(4):402-409. doi: 10.1016/S1473-3099(18)30650-9. Epub 2019 Mar 1.


The landscape of vaccines in China: history, classification, supply, and price.

Zheng Y, Rodewald L, Yang J, Qin Y, Pang M, Feng L, Yu H.

BMC Infect Dis. 2018 Oct 4;18(1):502. doi: 10.1186/s12879-018-3422-0.


Single-Cell Transcriptomes Distinguish Stem Cell State Changes and Lineage Specification Programs in Early Mammary Gland Development.

Giraddi RR, Chung CY, Heinz RE, Balcioglu O, Novotny M, Trejo CL, Dravis C, Hagos BM, Mehrabad EM, Rodewald LW, Hwang JY, Fan C, Lasken R, Varley KE, Perou CM, Wahl GM, Spike BT.

Cell Rep. 2018 Aug 7;24(6):1653-1666.e7. doi: 10.1016/j.celrep.2018.07.025.


Progress in Vaccine-Preventable and Respiratory Infectious Diseases-First 10 Years of the CDC National Center for Immunization and Respiratory Diseases, 2006-2015.

Schuchat A, Anderson LJ, Rodewald LE, Cox NJ, Hajjeh R, Pallansch MA, Messonnier NE, Jernigan DB, Wharton M.

Emerg Infect Dis. 2018 Jul;24(7):1178-1187. doi: 10.3201/eid2407.171699.


Routine immunization services costs and financing in China, 2015.

Yu W, Lu M, Wang H, Rodewald L, Ji S, Ma C, Li Y, Zheng J, Song Y, Wang M, Wang Y, Wu D, Cao L, Fan C, Zhang X, Liu Y.

Vaccine. 2018 May 17;36(21):3041-3047. doi: 10.1016/j.vaccine.2018.04.008. Epub 2018 Apr 20.


Knowledge, attitudes, and practices regarding hepatitis B vaccination among hospital-based doctors and nurses in China: Results of a multi-site survey.

Liu Y, Ma C, Jia H, Xu E, Zhou Y, Zhang Z, Lu L, Rodewald L, Hao L.

Vaccine. 2018 Apr 19;36(17):2307-2313. doi: 10.1016/j.vaccine.2018.03.018. Epub 2018 Mar 19.


Transmission of measles among healthcare Workers in Hospital W, Xinjiang Autonomous Region, China, 2016.

Jia H, Ma C, Lu M, Fu J, Rodewald LE, Su Q, Wang H, Hao L.

BMC Infect Dis. 2018 Jan 12;18(1):36. doi: 10.1186/s12879-018-2950-y.


Measles transmission among adults with spread to children during an outbreak: Implications for measles elimination in China, 2014.

Ma C, Yan S, Su Q, Hao L, Tang S, An Z, He Y, Fan G, Rodewald L, Wang H.

Vaccine. 2016 Dec 12;34(51):6539-6544. doi: 10.1016/j.vaccine.2016.02.051. Epub 2016 Jun 18.


Loss of confidence in vaccines following media reports of infant deaths after hepatitis B vaccination in China.

Yu W, Liu D, Zheng J, Liu Y, An Z, Rodewald L, Zhang G, Su Q, Li K, Xu D, Wang F, Yuan P, Xia W, Ning G, Zheng H, Chu Y, Cui J, Duan M, Hao L, Zhou Y, Wu Z, Zhang X, Cui F, Li L, Wang H.

Int J Epidemiol. 2016 Apr;45(2):441-9. doi: 10.1093/ije/dyv349.


Risk factors for measles infection in 0-7 month old children in China after the 2010 nationwide measles campaign: A multi-site case-control study, 2012-2013.

Ma C, Gregory CJ, Hao L, Wannemuehler KA, Su Q, An Z, Quick L, Rodewald L, Ma F, Yan R, Song L, Zhang Y, Kong Y, Zhang X, Wang H, Li L, Cairns L, Wang N, Luo H.

Vaccine. 2016 Dec 12;34(51):6553-6560. doi: 10.1016/j.vaccine.2016.02.002. Epub 2016 Mar 21.


Risk factors for measles in children aged 8 months-14 years in China after nationwide measles campaign: A multi-site case-control study, 2012-2013.

Hao L, Ma C, Wannemuehler KA, Su Q, An Z, Cairns L, Quick L, Rodewald L, Liu Y, He H, Xu Q, Ma Y, Yu W, Zhang N, Li L, Wang N, Luo H, Wang H, Gregory CJ.

Vaccine. 2016 Dec 12;34(51):6545-6552. doi: 10.1016/j.vaccine.2016.02.005. Epub 2016 Feb 11.


The effect of heterogeneity in uptake of the measles, mumps, and rubella vaccine on the potential for outbreaks of measles: a modelling study.

Glasser JW, Feng Z, Omer SB, Smith PJ, Rodewald LE.

Lancet Infect Dis. 2016 May;16(5):599-605. doi: 10.1016/S1473-3099(16)00004-9. Epub 2016 Feb 5.


Endemic and imported measles virus-associated outbreaks among adults, Beijing, China, 2013.

Chen M, Zhang Y, Huang F, Wang H, Liu D, Li J, Rodewald L, Wu J, Deng Y, Xu W.

Emerg Infect Dis. 2015 Mar;21(3):477-9. doi: 10.3201/eid2103.140646.


Measles vaccine coverage estimates in an outbreak three years after the nation-wide campaign in China: implications for measles elimination, 2013.

Ma C, Li F, Zheng X, Zhang H, Duan M, Yang Y, Hao L, Su Q, Rodewald L, Guo B, Xiao S, Wang H, Li L, Li J, Luo H, Gao L.

BMC Infect Dis. 2015 Jan 22;15:23. doi: 10.1186/s12879-015-0752-z.


A versatile platform to analyze low-affinity and transient protein-protein interactions in living cells in real time.

Li YC, Rodewald LW, Hoppmann C, Wong ET, Lebreton S, Safar P, Patek M, Wang L, Wertman KF, Wahl GM.

Cell Rep. 2014 Dec 11;9(5):1946-1958. doi: 10.1016/j.celrep.2014.10.058. Epub 2014 Nov 20.


Monitoring progress towards the elimination of measles in China: an analysis of measles surveillance data.

Ma C, Hao L, Zhang Y, Su Q, Rodewald L, An Z, Yu W, Ma J, Wen N, Wang H, Liang X, Wang H, Yang W, Li L, Luo H.

Bull World Health Organ. 2014 May 1;92(5):340-7. doi: 10.2471/BLT.13.130195. Epub 2014 Feb 5. Erratum in: Bull World Health Organ. 2014 Aug 1;92(8):620.


Economic evaluation of the routine childhood immunization program in the United States, 2009.

Zhou F, Shefer A, Wenger J, Messonnier M, Wang LY, Lopez A, Moore M, Murphy TV, Cortese M, Rodewald L.

Pediatrics. 2014 Apr;133(4):577-85. doi: 10.1542/peds.2013-0698. Epub 2014 Mar 3.


Notes from the field: my experience in China with WHO.

Rodewald LE.

Pediatr Ann. 2013 Jun 1;42(6):253-5. doi: 10.3928/00904481-20130522-13. No abstract available.


Paracrine Wnt signaling both promotes and inhibits human breast tumor growth.

Green JL, La J, Yum KW, Desai P, Rodewald LW, Zhang X, Leblanc M, Nusse R, Lewis MT, Wahl GM.

Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):6991-6. doi: 10.1073/pnas.1303671110. Epub 2013 Apr 4.


Structures, roles, and procedures of state advisory committees on immunization.

Dolen V, Talkington K, Bhatt A, Rodewald L.

J Public Health Manag Pract. 2013 Nov-Dec;19(6):582-8. doi: 10.1097/PHH.0b013e318271c738.


Functional analysis and consequences of Mdm2 E3 ligase inhibition in human tumor cells.

Wade M, Li YC, Matani AS, Braun SM, Milanesi F, Rodewald LW, Wahl GM.

Oncogene. 2012 Nov 8;31(45):4789-97. doi: 10.1038/onc.2011.625. Epub 2012 Jan 23.


Vaccination coverage among U.S. adolescents aged 13-17 years eligible for the Vaccines for Children program, 2009.

Lindley MC, Smith PJ, Rodewald LE.

Public Health Rep. 2011 Jul-Aug;126 Suppl 2:124-34.


Vaccination coverage among U.S. children aged 19-35 months entitled by the Vaccines for Children program, 2009.

Smith PJ, Lindley MC, Rodewald LE.

Public Health Rep. 2011 Jul-Aug;126 Suppl 2:109-23.


Financing the delivery of vaccines to children and adolescents: challenges to the current system.

Lindley MC, Shen AK, Orenstein WA, Rodewald LE, Birkhead GS.

Pediatrics. 2009 Dec;124 Suppl 5:S548-57. doi: 10.1542/peds.2009-1542O.


Perspective of vaccine manufacturers on financing pediatric and adolescent vaccines in the United States.

Shen AK, Rodewald LE, Birkhead GS.

Pediatrics. 2009 Dec;124 Suppl 5:S540-7. doi: 10.1542/peds.2009-1542N.


Underinsurance and adolescent immunization delivery in the United States.

Smith PJ, Lindley MC, Shefer A, Rodewald LE.

Pediatrics. 2009 Dec;124 Suppl 5:S515-21. doi: 10.1542/peds.2009-1542K.


Underinsurance and pediatric immunization delivery in the United States.

Smith PJ, Molinari NA, Rodewald LE.

Pediatrics. 2009 Dec;124 Suppl 5:S507-14. doi: 10.1542/peds.2009-1542J.


Net financial gain or loss from vaccination in pediatric medical practices.

Coleman MS, Lindley MC, Ekong J, Rodewald L.

Pediatrics. 2009 Dec;124 Suppl 5:S472-91. doi: 10.1542/peds.2009-1542G.


Vaccinating adolescents--new evidence of challenges and opportunities.

Rodewald LE, Orenstein WA.

J Adolesc Health. 2009 Nov;45(5):427-9. doi: 10.1016/j.jadohealth.2009.08.006. No abstract available.


Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America.

Pickering LK, Baker CJ, Freed GL, Gall SA, Grogg SE, Poland GA, Rodewald LE, Schaffner W, Stinchfield P, Tan L, Zimmerman RK, Orenstein WA; Infectious Diseases Society of America.

Clin Infect Dis. 2009 Sep 15;49(6):817-40. doi: 10.1086/605430. Erratum in: Clin Infect Dis. 2009 Nov 1;49(9):1465.


Preventing vaccine-preventable diseases in low-resource communities.

Rodewald LE, Markowitz LE.

Arch Pediatr Adolesc Med. 2009 May;163(5):487-8. doi: 10.1001/archpediatrics.2009.76. No abstract available.


BH3 activation blocks Hdmx suppression of apoptosis and cooperates with Nutlin to induce cell death.

Wade M, Rodewald LW, Espinosa JM, Wahl GM.

Cell Cycle. 2008 Jul 1;7(13):1973-82.


Quantitative analyses reveal the importance of regulated Hdmx degradation for p53 activation.

Wang YV, Wade M, Wong E, Li YC, Rodewald LW, Wahl GM.

Proc Natl Acad Sci U S A. 2007 Jul 24;104(30):12365-70. Epub 2007 Jul 17.


Balancing the childhood immunization program with the urgent needs for adult hepatitis B immunization.

Rodewald LE, Tan L.

Public Health Rep. 2007;122 Suppl 2:52-4. No abstract available.


A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.

Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L, Rodewald LE, Douglas JM Jr, Janssen RS, Ward JW; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2006 Dec 8;55(RR-16):1-33; quiz CE1-4. Erratum in: MMWR Morb Mortal Wkly Rep. 2007 Oct 26;56(42):1114.


Mouse mutants reveal that putative protein interaction sites in the p53 proline-rich domain are dispensable for tumor suppression.

Toledo F, Lee CJ, Krummel KA, Rodewald LW, Liu CW, Wahl GM.

Mol Cell Biol. 2007 Feb;27(4):1425-32. Epub 2006 Dec 11.


Too hot, too cold: issues with vaccine storage.

Pickering LK, Wallace G, Rodewald L.

Pediatrics. 2006 Oct;118(4):1738-9. No abstract available.


A mouse p53 mutant lacking the proline-rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory network.

Toledo F, Krummel KA, Lee CJ, Liu CW, Rodewald LW, Tang M, Wahl GM.

Cancer Cell. 2006 Apr;9(4):273-85.


For better immunisation coverage, measure coverage better.

Papania M, Rodewald L.

Lancet. 2006 Mar 25;367(9515):965-6. No abstract available.


Vaccine shortages: history, impact, and prospects for the future.

Hinman AR, Orenstein WA, Santoli JM, Rodewald LE, Cochi SL.

Annu Rev Public Health. 2006;27:235-59. Review.


Vaccine supply problems: a perspective of the Centers for Disease Control and Prevention.

Rodewald LE, Orenstein WA, Mason DD, Cochi SL.

Clin Infect Dis. 2006 Mar 1;42 Suppl 3:S104-10.


Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.

Zhou F, Santoli J, Messonnier ML, Yusuf HR, Shefer A, Chu SY, Rodewald L, Harpaz R.

Arch Pediatr Adolesc Med. 2005 Dec;159(12):1136-44.


The association between having a medical home and vaccination coverage among children eligible for the vaccines for children program.

Smith PJ, Santoli JM, Chu SY, Ochoa DQ, Rodewald LE.

Pediatrics. 2005 Jul;116(1):130-9.


Interventions to improve influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among high-risk adults: a systematic review.

Ndiaye SM, Hopkins DP, Shefer AM, Hinman AR, Briss PA, Rodewald L, Willis B; Task Force on Community Preventive Services.

Am J Prev Med. 2005 Jun;28(5 Suppl):248-79. Review. No abstract available.


Supplemental Content

Loading ...
Support Center